Education
About Us
Working with TipRanks
Follow Us
Ss Innovations International, Inc (SSII)
:SSII
SSII Stock Chart & Stats
$6.42
$0.01(0.13%)
At close: 4:00 PM EST
$6.42
$0.01(0.13%)
Day’s Range― - ―
52-Week Range$3.02 - $22.42
Previous CloseN/A
Volume157.00
Average Volume (3M)75.14K
Market Cap
$1.11B
Enterprise Value$1.26B
Total Cash (Recent Filing)$11.71M
Total Debt (Recent Filing)$12.68M
Price to Earnings (P/E)―
Beta9.84
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding193,621,150
10 Day Avg. Volume101,232
30 Day Avg. Volume75,142
Financial Highlights & Ratios
PEG Ratio2.25
Price to Book (P/B)100.13
Price to Sales (P/S)65.25
P/FCF Ratio-132.57
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue37.51
Enterprise Value/Gross Profit77.74
Enterprise Value/Ebitda-96.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SS Innovations International News
SSII FAQ
What was Ss Innovations International, Inc’s price range in the past 12 months?
Ss Innovations International, Inc lowest stock price was $3.02 and its highest was $22.42 in the past 12 months.
What is Ss Innovations International, Inc’s market cap?
Ss Innovations International, Inc’s market cap is $1.11B.
When is Ss Innovations International, Inc’s upcoming earnings report date?
Ss Innovations International, Inc’s upcoming earnings report date is Aug 07, 2025 which is 137 days ago.
How were Ss Innovations International, Inc’s earnings last quarter?
Ss Innovations International, Inc released its earnings results on Aug 07, 2025. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
Is Ss Innovations International, Inc overvalued?
According to Wall Street analysts Ss Innovations International, Inc’s price is currently Overvalued.
Does Ss Innovations International, Inc pay dividends?
Ss Innovations International, Inc does not currently pay dividends.
What is Ss Innovations International, Inc’s EPS estimate?
Ss Innovations International, Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ss Innovations International, Inc have?
Ss Innovations International, Inc has 193,621,150 shares outstanding.
What happened to Ss Innovations International, Inc’s price movement after its last earnings report?
Ss Innovations International, Inc reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.526%.
Which hedge fund is a major shareholder of Ss Innovations International, Inc?
Currently, no hedge funds are holding shares in SSII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SS Innovations International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
SSII Sentiment 70%
Sector Average ―
Sector Average ―
Crowd Wisdom
Neutral
Last 7 Days ▼ 4.9%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
14.50%
12-Months-Change
Fundamentals
Return on Equity
-43.42%
Trailing 12-Months
Asset Growth
78.31%
Trailing 12-Months
Company Description
Ss Innovations International, Inc
SS Innovations International (SSII) is a leading technology firm that specializes in developing cutting-edge software solutions and hardware products for various sectors, including telecommunications, healthcare, and manufacturing. The company focuses on innovation and efficiency, delivering high-quality products such as enterprise software platforms, IoT devices, and customized IT services designed to enhance operational performance and drive digital transformation for its clients.
Technical Analysis
Conmed
―
Artivion
―
Integra Lifesciences
―
Tandem Diabetes Care
―
Establishment Labs Holdings
―
Ownership Overview
70.59% Insiders
0.03% Mutual Funds
0.11% Other Institutional Investors
29.22% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---